BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26471874)

  • 1. Drug-related HIV epidemic in Pakistan: a review of current situation and response and the way forward beyond 2015.
    Bergenstrom A; Achakzai B; Furqan S; ul Haq M; Khan R; Saba M
    Harm Reduct J; 2015 Oct; 12():43. PubMed ID: 26471874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.
    Larney S; Peacock A; Leung J; Colledge S; Hickman M; Vickerman P; Grebely J; Dumchev KV; Griffiths P; Hines L; Cunningham EB; Mattick RP; Lynskey M; Marsden J; Strang J; Degenhardt L
    Lancet Glob Health; 2017 Dec; 5(12):e1208-e1220. PubMed ID: 29074410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
    Stone KA
    Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
    Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
    Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug scene, drug use and drug-related health consequences and responses in Kulob and Khorog, Tajikistan.
    Latypov A; Otiashvili D; Zule W
    Int J Drug Policy; 2014 Nov; 25(6):1204-14. PubMed ID: 25449057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. People who inject drugs in Bangladesh - The untold burden!
    Khan SI; Reza MM; Crowe SM; Rahman M; Hellard M; Sarker MS; Chowdhury EI; Rana AKMM; Sacks-Davis R; Banu S; Ross AG
    Int J Infect Dis; 2019 Jun; 83():109-115. PubMed ID: 30928433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.
    Cepeda JA; Eritsyan K; Vickerman P; Lyubimova A; Shegay M; Odinokova V; Beletsky L; Borquez A; Hickman M; Beyrer C; Martin NK
    Lancet HIV; 2018 Oct; 5(10):e578-e587. PubMed ID: 30033374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada.
    Jacka B; Larney S; Degenhardt L; Janjua N; Høj S; Krajden M; Grebely J; Bruneau J
    Am J Public Health; 2020 Jan; 110(1):45-50. PubMed ID: 31725310
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015-2016: A multi-method estimation study.
    Thanki D; Mravčík V; Běláčková V; Mačiulytė D; Zábranský T; Širvinskienė A; Subata E; Lorenzo-Ortega R
    J Subst Abuse Treat; 2021 Mar; 122():108229. PubMed ID: 33509418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
    Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
    Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature.
    Grenfell P; Baptista Leite R; Garfein R; de Lussigny S; Platt L; Rhodes T
    Drug Alcohol Depend; 2013 May; 129(3):180-209. PubMed ID: 23306095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV and HCV among people who inject drugs in Central Asia.
    Walsh N; Maher L
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S37-40. PubMed ID: 23906997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coverage of harm reduction services and HIV infection: a multilevel analysis of five Chinese cities.
    Wu Q; Kamphuis C; Duo L; Luo J; Chen Y; Richardus JH
    Harm Reduct J; 2017 Feb; 14(1):10. PubMed ID: 28193236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revitalizing the HIV response in Pakistan: a systematic review and policy implications.
    Singh S; Ambrosio M; Semini I; Tawil O; Saleem M; Imran M; Beyrer C
    Int J Drug Policy; 2014 Jan; 25(1):26-33. PubMed ID: 23810289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
    Tan J; Altice FL; Madden LM; Zelenev A
    Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modeling.
    Vickerman P; Platt L; Jolley E; Rhodes T; Kazatchkine MD; Latypov A
    Int J Drug Policy; 2014 Nov; 25(6):1163-73. PubMed ID: 25449056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.